Overview

Autoimmunity in Retinitis Pigmentosa

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

Using local immune suppression, the trial seeks evidence for the hypothesis that autoimmunity plays a role in the pathomechanism of retinitis pigmentosa.

Phase:

N/A

Details

Lead Sponsor:

Semmelweis University

Treatments:

Cyclosporine
Cyclosporins
Ophthalmic Solutions